Routine vs. On-Demand Discharge Planning Strategy in Intermediate-Risk Patients for Complex Discharge: a Cluster-Randomized, Multiple Crossover Trial

被引:0
|
作者
Evangelista, Andrea [1 ]
Camussi, Elisa [2 ]
Corezzi, Michele [3 ]
Gilardetti, Marco [1 ]
Fonte, Gianfranco [2 ]
Scarmozzino, Antonio [4 ]
La Valle, Giovanni [4 ]
Angelone, Lorenzo [4 ]
Olivero, Elena [4 ]
Ciccone, Giovannino [1 ]
Corsi, Daniela [4 ]
机构
[1] AOU Citta Salute & Sci Torino & CPO Piemonte, Unit Clin Epidemiol, Via Santena 7, I-10126 Turin, Italy
[2] AOU Citta Salute & Sci Torino & CPO Piemonte, Unit Screening Epidemiol, Turin, Italy
[3] AOU Citta Salute & Sci Torino, Qual & Safety Care Dept, Turin, Italy
[4] AOU Citta Salute & Sci Torino, Hosp Med Direct, Turin, Italy
关键词
discharge planning; continuity of care; hospital readmission; cluster-randomized trial;
D O I
10.1007/s11606-023-08186-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundEarly hospital discharge planning can help to reduce the length of stay and unplanned readmission in high-risk patients. Therefore, it is important to select patients who can benefit from a personalized discharge planning based on validated tools. The modified Blaylock Risk Assessment Screening Score (BRASS) is routinely used in the Molinette Hospital (Turin, Italy) to screen patients at high risk for discharge, but the effectiveness of the discharge planning is uncertain in intermediate-risk patients.ObjectiveTo evaluate the best strategy for discharge planning by the Continuity of Care Hospital Unit (CCHU) in intermediate-risk patients according to modified BRASS.DesignCluster-randomized, multiple crossover trial.ParticipantsAdult patients admitted in the Medicine and Neurology departments of the Molinette Hospital in Turin, Italy, between June 2018 and May 2019 with a BRASS intermediate risk.InterventionsA routine discharge planning strategy (RDP, Routine Discharge Plan), which involved the management of all intermediate-risk patients, was compared to an on-demand discharge planning strategy (DDP, on-Demand Discharge Planning), which involved only selected patients referred to the CCHU by ward staff.Main MeasuresThe primary outcome was the 90-day hospital readmission for any cause (HR90). Secondary outcomes included the prolonged length of stay (pLOS).Key ResultsEight hundred two patients (median age 79 years) were included (414 RDP and 388 DDP). Comparing RDP vs. DDP periods, HR90 was 27.6% and 27.3% (OR 1.01, 90%CI 0.76-1.33, p = 0.485); and pLOS was 47 (11.4%) and 40 (10.3%) (OR 1.24, 95%CI 0.72-2.13, p = 0.447), respectively.ConclusionsThis is one of the largest randomized study conducted to compare the effectiveness of two different hospital discharge planning strategies. In patients with intermediate risk of hospital discharge, a RDP offers no advantage over a DDP and results in an unnecessary increase in staff workload.
引用
收藏
页码:2749 / 2754
页数:6
相关论文
共 4 条
  • [1] Routine vs. On-Demand Discharge Planning Strategy in Intermediate-Risk Patients for Complex Discharge: a Cluster-Randomized, Multiple Crossover Trial
    Andrea Evangelista
    Elisa Camussi
    Michele Corezzi
    Marco Gilardetti
    Gianfranco Fonte
    Antonio Scarmozzino
    Giovanni La Valle
    Lorenzo Angelone
    Elena Olivero
    Giovannino Ciccone
    Daniela Corsi
    Journal of General Internal Medicine, 2023, 38 : 2749 - 2754
  • [2] Efficacy of a Discharge Educational Strategy vs Standard Discharge Care on Reduction of Vascular Risk in Patients With Stroke and Transient Ischemic Attack The DESERVE Randomized Clinical Trial
    Boden-Albala, Bernadette
    Goldmann, Emily
    Parikh, Nina S.
    Carman, Heather
    Roberts, Eric T.
    Lord, Aaron S.
    Torrico, Veronica
    Appleton, Noa
    Birkemeier, Joel
    Parides, Michael
    Quarles, Leigh
    JAMA NEUROLOGY, 2019, 76 (01) : 20 - 27
  • [3] Re: Enzalutamide Monotherapy vs. Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2023, 209 (03): : 636 - 637
  • [4] Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial
    Giannitsis, Evangelos
    Garfias-Veitl, Tania
    Slagman, Anna
    Searle, Julia
    Mueller, Christian
    Blankenberg, Stefan
    von Haehling, Stephan
    Katus, Hugo A.
    Hamm, Christian W.
    Huber, Kurt
    Vollert, Joern O.
    Moeckel, Martin
    CELLS, 2022, 11 (02)